LEGN
Legend Biotech Corporation
Legend Biotech Corporation insider trading
Legend Biotech Corporation files with the SEC as a Pharmaceutical Preparations company headquartered in Somerset, NJ. Every time one of its executives or directors buys or sells the stock, the filing appears here the moment it reaches the SEC — with grants and option exercises set apart from the trades that cost the insider their own money.
From SEC filings
Recent LEGN insider transactions
2 insiders traded LEGN on the open market between Mar 25, 2026 and Jun 30, 2026 — 3 sales worth $258.2K.
- Bought
- —
- Sold
- $258.2K
- Net
- −$258.2K
- Insiders
- 2
none on a 10b5-1 plan
Casey Patrick John
Director
−$88.8K
Jun 30, 2026
6,000 sh · $14.80
Huang Ying
Chief Executive Officer · Director
−$82.3K
Jun 25, 2026
5,566 sh · $14.78
Huang Ying
Chief Executive Officer · Director
−$87.1K
Mar 25, 2026
9,936 sh · $8.77
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Jun 30, 2026 | Casey Patrick JohnDirector | 6,000 | $14.80 | −$88.8K |
| Jun 25, 2026 | Huang YingChief Executive Officer · Director | 5,566 | $14.78 | −$82.3K |
| Mar 25, 2026 | Huang YingChief Executive Officer · Director | 9,936 | $8.77 | −$87.1K |
SEC Form 4 data, Q3 2024 to Q2 2026
LEGN insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, one insider traded LEGN on the open market: 0 purchases and 2 sales worth $169.4K. In the last four quarters alone: 0 purchases and 2 sales ($169.4K), by one insider.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | — | −$82.3K1 sale | |
| Q1 2026 | — | −$87.1K1 sale | |
| Q4 2025 | — | — | |
| Q3 2025 | — | — | |
| Q2 2025 | — | — | |
| Q1 2025 | — | — | |
| Q4 2024 | — | — | |
| Q3 2024 | — | — |
- Largest sale
- −$87.1K of LEGN by Huang Ying (Chief Executive Officer · Director) on Mar 25, 2026.
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
Legend Biotech Corporation company record
- SEC industry classification
- Pharmaceutical Preparations
- Headquarters
- Somerset, NJ
- Incorporated in
- E9
- Listed on
- Nasdaq
- SEC Central Index Key
- 0001801198
Sourced from this company's own SEC submissions record. The industry label is SEC's Standard Industrial Classification, which is more specific than the Health Care sector shown above.
After insiders bought LEGN
What the stock actually did in the 90 days following each open-market purchase
Don't check LEGN — let it ping you
Get told the moment an insider moves on LEGN
Pro watches Legend Biotech Corporation for you and sends a Telegram ping within moments of a Form 4 clearing EDGAR — a C-suite open-market buy, a cluster, a 10b5-1 regime break — long before it reaches the press. Add LEGN to a watchlist, see each mover's benchmark-measured track record and which legendary funds hold it, and read the full filing history instead of the last 72 hours.
The live dashboard is free to open. Alerts, watchlists, full filing history and each mover's benchmark-measured track record are Pro. Monitoring, not advice.
How to read LEGN insider activity
- Open-market purchase (code P)
- An insider spending their own money at market price. This is the only buy code that reliably carries signal — it is a decision, not compensation.
- Grants and option exercises (codes A, M)
- Scheduled compensation. Most "insider buying" headlines are really this, which is why InsiderPulse weights it at a fraction of a real purchase.
- Cluster buy
- Two or more different insiders buying on the open market in the same window. One executive buying can mean anything; three is much harder to explain away.
Other Health Care tickers
Questions
- Are LEGN insiders buying or selling?
- Between Mar 25, 2026 and Jun 30, 2026, 2 Legend Biotech Corporation insiders made no open-market purchases and 3 sales worth $258.2K, a net sale of $258.2K.
- How much LEGN stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 1 Legend Biotech Corporation insider made no open-market purchases and 2 sales worth $169.4K. In the four quarters to Jun 30, 2026: no purchases and 2 sales ($169.4K). The largest sale was Huang Ying selling $87.1K on Mar 25, 2026.
- What was the largest recent LEGN insider trade?
- Casey Patrick John (Director) sold $88.8K of LEGN stock on Jun 30, 2026 at about $14.80 a share.
- When did an insider last buy LEGN shares?
- No open-market purchase by a Legend Biotech Corporation insider appears in the filings from Mar 25, 2026 to Jun 30, 2026 — every recorded open-market transaction in that period was a sale.
- Where does LEGN insider trading data come from?
- From the Form 4 filings Legend Biotech Corporation's officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.